Mera Pharmaceuticals, Inc. (MRPI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
Mera Pharmaceuticals Market Cap
Mera Pharmaceuticals has a market cap or net worth of $537 as of March 5, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
537.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 2, 1993, Mera Pharmaceuticals's market cap has decreased from 1.56M to 537.00, a decrease of -99.97%. That is a compound annual growth rate of -21.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 537.00 | -99.04% |
| Dec 30, 2022 | 55.68K | -50.00% |
| Dec 31, 2021 | 111.36K | -95.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |
| Nabriva Therapeutics | 646.00 |
| Amarantus BioScience Holdings | 630.00 |
| Adynxx | 581.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Alzex Neuropharma | 452.00 |